Ace the CRNI Challenge 2026 – Infuse Your Career with Success!

The upper body insertion of a central venous access device (CVAD) typically terminates in the superior vena cava (SVC). This is because the SVC is strategically located to facilitate the rapid delivery of infused fluids and medications into the central circulation, ensuring quick distribution throughout the body.

CVADs inserted through the upper body, such as those placed in the jugular or subclavian veins, are designed to thread through these veins until they reach the SVC. This positioning maximizes the efficacy of the treatment and helps in achieving optimal hemodynamic stability and monitoring if needed. The choice of the SVC also allows for the avoidance of complications that could arise from other veins farther away from the heart, thereby enhancing patient safety and treatment efficiency.

In contrast, the inferior vena cava (IVC) is typically accessed through lower body approaches, such as the femoral vein, which are not associated with upper body insertions. The femoral vein itself is located in the groin area and not considered as a termination point for upper body CVADs. Therefore, the most accurate answer regarding the termination of CVADs inserted in the upper body is indeed the superior vena cava.